Clinical Trial Update: A Safety and Efficacy Study to Evaluate Rosacea [Phase 1, Phase 2]

View source ↗

Summary

The Phase 1/2 trial for papulopustular rosacea sponsored by AiViva BioPharma has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rosacea

Snippet

Sponsor: AiViva BioPharma, Inc. | Conditions: Papulopustular Rosacea | Phase 1, Phase 2 | Status: WITHDRAWN